Physician profile
Andrew Thome
NPI 1326426925
$24,028.63
in general payments reported to CMS, 2019-2025
18 companies · $1,012 in 2025
The $1,012 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $729 · 2021: $1,914 · 2022: $17K · 2023: $1,277 · 2024: $952 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,788 · Travel and Lodging: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,788.34 |
| Travel and Lodging | $453.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $14,828.78 | 2022 | |
| Stryker Corporation | $3,909.10 | 2019-2025 | Augment Injectable, Infinity, Inbone |
| Pylant Medical | $1,221.87 | 2022 | |
| Elite Orthopedics, LLC | $863.62 | 2022-2025 | |
| Paragon 28, INC. | $828.07 | 2023-2025 | Phantom Fibula Nail, Silverback, Monkey Rings |
| Medical Device Business Services, INC. | $737.98 | 2019-2021 | |
| Depuy Synthes Sales INC. | $461.51 | 2020-2024 | Na |
| Zimmer Biomet Holdings, INC. | $258.87 | 2020-2021 | |
| Linvatec Corporation | $240.98 | 2024-2025 | Biobrace 23mm, Neospan |
| Medline Industries LP | $185.27 | 2022-2024 | |
| Acera Surgical, INC. | $139.43 | 2023 | Restrata Wound Matrix |
| Orthofix Medical, INC. | $101.65 | 2022 | |
| Smith+Nephew, INC. | $89.94 | 2022 | |
| Djo, LLC | $76.69 | 2021 | |
| Treace Medical Concepts, INC. | $30.28 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $21.35 | 2023 | |
| Heron Therapeutics, INC. | $18.53 | 2023 | Zynrelef |
| Merck Sharp & Dohme LLC | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Thome listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.